Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of a CCT-102 Regimen or Expectant Management in the Treatment of First Trimester Pregnancy Loss

NCT06121063 is registered in ClinicalTrials.gov with Conceptra Biosciences, LLC as lead sponsor.

NCT NCT06121063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06121063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of a CCT-102 Regimen or Expectant Management in the Treatment of First Trimester Pregnancy Loss
Lead sponsor
Conceptra Biosciences, LLC
Phase
Phase 3
Overall status
Completed
Start date
July 21, 2023
Completion date
July 30, 2025
Enrollment
183 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

early pregnancy loss, delayed pregnancy loss